This resulted in a halt of foreign medical tourism, especially those from Indonesia, which is the bulk of the group’s portfolio.
SINGAPORE (Apr 1): RHB is keeping its “buy” recommendation on TalkMed with a lowered target price of 53 cents from 62 cents previously.
With the ongoing travel restrictions in place due to the Covid-19 outbreak, TalkMed will be seeing a drop in the number of medical tourists, as international visitors are not allowed to enter Singapore for short-term trips.
